All the pro-inflammatory biomarkers (IL-1β, IL-6, IL-8, and TNF-α) were positively correlated with the clinical parameters at baseline or following completed treatment, except for the PCR in subjects with hypertension. This evidence concerns the gene IL1B and Hypertension.